M&A advisory across the largest, most active sector in healthcare services — physician practice management and dental services.
Cath labs, diagnostic testing, and value-based positioning drive intense buyer competition.
Cosmetic mix, ancillary aesthetics, and strong cash-pay margins make derm a top PE-backed sector.
Subscription revenue and value-based care alignment drive emerging investor interest.
Allergy testing, in-office procedures, and high commercial reimbursement fuel platform formation.
Endoscopy ownership, screening tailwinds, and ancillary pathology power one of the fiercest buyer markets.
High-margin cash-pay revenue and recurring injectable treatments drive premium hybrid models.
GLP-1 prescription volume is fueling new tech-enabled platform formation at speed.
Dialysis-linked platforms and value-based kidney care models attract niche PE interest.
Spine procedure volume and outpatient migration are creating selective platform opportunities.
Drug administration economics and clinical trial infrastructure power distributor-led acquisitions.
Cataract volume, retina sub-specialization, and diagnostic ancillaries command premium multiples.
Retail optical revenue and recurring exam volume drive ongoing vision platform consolidation.
Implant revenue, high-acuity procedures, and a commercial + cash-pay blend command platform premiums.
ASC integration and joint replacement volume are reshaping how the sector consolidates.
Procedure-based reimbursement, interventional volume, and ASC integration drive maturing platforms.
GI biopsy processing, dermatopathology, and molecular diagnostics anchor lab-linked roll-ups.
PE investments tripled YoY in 2025, fueled by demographic demand and behavioral adjacencies.
Cash-pay dominance and recurring aesthetics command the highest cash-pay multiples in PPM.
Medicare Advantage, ACO REACH, and capitated contracts attract payvider and PE interest.
Drug administration, ASC procedures, and male health services define a new wave of distributor M&A.
Recurring pet health spend and specialty / emergency consolidation drive durable consumer demand.
OB/GYN procedures, fertility sub-specialization, and behavioral adjacencies anchor multiple PE platforms.
Specialty-by-specialty M&A intelligence, valuation benchmarks, recent transactions, and investor dynamics across the physician practice management and dental services landscape.